Cargando…
miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF α
The median survival time of breast cancer patients with brain metastasis is less than 6 months, and even a small metastatic lesion often causes severe neurological disabilities. Because of the location of metastatic lesions, a surgical approach is limited and most chemotherapeutic drugs are ineffect...
Autores principales: | Xing, Fei, Sharma, Sambad, Liu, Yin, Mo, Yin-Yuan, Wu, Kerui, Zhang, Ying-Yu, Pochampally, Radhika, Martinez, Luis A, Lo, Hui-wen, Watabe, Kounosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530094/ https://www.ncbi.nlm.nih.gov/pubmed/25659578 http://dx.doi.org/10.1038/onc.2014.412 |
Ejemplares similares
-
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
por: Singh, Ramesh, et al.
Publicado: (2014) -
Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions
por: Wu, Shih-Ying, et al.
Publicado: (2021) -
Specific role of RhoC in tumor invasion and metastasis
por: Lang, Sarah, et al.
Publicado: (2017) -
Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway
por: Gupta, Subash C., et al.
Publicado: (2014) -
A RhoC Biosensor Reveals Differences in the Activation Kinetics of RhoA and RhoC in Migrating Cells
por: Zawistowski, Jon S., et al.
Publicado: (2013)